Wodka; Dariusz

Patent Applications and Registrations

Patent applications and USPTO patent grants for Wodka; Dariusz.The latest application filed is for "treatment of central nervous system disorders".

Company Profile

0.20.23

Wodka; Dariusz - Monmouth Junction NJ
Wodka; Dariusz - Whitetown IN
Wodka; Dariusz - Plainsboro NJ
Wodka; Dariusz - Waukegan IL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Treatment of central nervous system disorders Grant 9,464,072 - Bitner , et al. October 11, 2	2016-10-11
Methods of use of inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme Grant 9,133,145 - Bitner , et al. September 15, 2	2015-09-15
Treatment Of Central Nervous System Disorders App 20150099740 - Bitner; R. Scott ; et al.	2015-04-09
Treatment of central nervous system disorders Grant 8,940,902 - Bitner , et al. January 27, 2	2015-01-27
Methods Of Use Of Inhibitors Of The 11-beta-hydroxysteroid Dehydrogenase Type 1 Enzyme App 20130338169 - Bitner; R. Scott ; et al.	2013-12-19
Cyclic benzimidazole derivatives useful as anti-diabetic agents Grant 8,563,746 - Dang , et al. October 22, 2	2013-10-22
Methods of use of inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme Grant 8,415,354 - Bitner , et al. April 9, 2	2013-04-09
Cyclic benzimidazole derivatives useful as anti-diabetic agents Grant 8,410,284 - Dang , et al. April 2, 2	2013-04-02
Cyclic benzimidazole derivatives useful as anti-diabetic agents Grant 8,394,969 - Bookser , et al. March 12, 2	2013-03-12
Treatment Of Central Nervous System Disorders App 20130059829 - Bitner; R. Scott ; et al.	2013-03-07
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme Grant 8,372,841 - Pliushchev , et al. February 12, 2	2013-02-12
Cyclic benzimidazole derivatives useful as anti-diabetic agents Grant 8,329,914 - Bao , et al. December 11, 2	2012-12-11
Inhibitors Of The 11-beta-hydroxysteroid Dehydrogenase Type 1 Enzyme App 20120004206 - Pliushchev; Marina A. ; et al.	2012-01-05
Novel Cyclic Benzimidazole Derivatives Useful As Anti-diabetic Agents App 20110263533 - Dang; Qun ; et al.	2011-10-27
Novel Cyclic Benzimidazole Derivatives Useful As Anti-diabetic Agents App 20110218174 - Bao; Jianming ; et al.	2011-09-08
Novel Cyclic Benzimidazole Derivatives Useful As Anti-diabetic Agents App 20110195964 - Dang; Qun ; et al.	2011-08-11
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme Grant 7,880,001 - Link , et al. February 1, 2	2011-02-01
Inhibitors Of The 11-beta-hydroxysteroid Dehydrogenase Type 1 Enzyme App 20100222316 - Pliushchev; Marina A. ; et al.	2010-09-02
Treatment Of Central Nervous System Disorders App 20100152179 - Bitner; R. Scott ; et al.	2010-06-17
Novel Cyclic Benzimidazole Derivatives Useful As Anti-diabetic Agents App 20100081643 - BOOKSER; BRETT C. ; et al.	2010-04-01
Methods Of Use Of Inhibitors Of The 11-beta-hydroxysteroid Dehydrogenase Type 1 Enzyme App 20090192141 - Bitner; R. Scott ; et al.	2009-07-30
Treatment Of Central Nervous System Disorders App 20090054426 - Bitner; R. Scott ; et al.	2009-02-26
Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor Grant 7,071,182 - Souers , et al. July 4, 2	2006-07-04
Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor Grant 7,049,307 - Souers , et al. May 23, 2	2006-05-23
2-Aminoquinolines as melanin concentrating hormone receptor antagonists Grant 6,989,392 - Collins , et al. January 24, 2	2006-01-24
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme App 20050277647 - Link, James T. ; et al.	2005-12-15
Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor App 20050277638 - Souers, Andrew J. ; et al.	2005-12-15
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme App 20050245745 - Link, James T. ; et al.	2005-11-03
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme App 20050245534 - Link, James T. ; et al.	2005-11-03
Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor App 20050209274 - Lynch, John K. ; et al.	2005-09-22
Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor App 20050187279 - Souers, Andrew J. ; et al.	2005-08-25
Antagonists of melanin concentrating hormone receptor Grant 6,921,821 - Blackburn , et al. July 26, 2	2005-07-26
Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor App 20050137187 - Souers, Andrew J. ; et al.	2005-06-23
Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor App 20050137243 - Souers, Andrew J. ; et al.	2005-06-23
Antagonists of melanin concentrating hormone receptor App 20040106645 - Blackburn, Christopher ; et al.	2004-06-03
2-Aminoquinolines as melanin concentrating hormone receptor antagonists App 20040063756 - Collins, Christine A. ; et al.	2004-04-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.